Gastroenterology

Gastrointestinal symptoms were significantly linked to severe symptoms of depression and anxiety.

Serious infections occurred in less than 2% of patients treated with the medication during the duration of the 52-week trial.

Just 7% of patients in the BPA group suffered a recurrent CDI episode within 14-56 days of initiating treatment.

Taste scores were significantly correlated with depression scores for both patients with irritable bowel syndrome and functional constipation.

The ongoing PIANO registry is designed to keep real time data on the outcomes of pregnant patients with IBD.

In research presented virtually at IDWeek 2021, investigators with the US Centers for Disease Control and Prevention conducted a review of nursing home antibiotic stewardship citation deficiencies in order to improve implementation.

Data from 5 trials presented at ID Week 2021 are promising for the investigational biotherapeutic.

Risky sexual behavior is the sole independent predictor of acute HDV.

Age, antibiotic use, and proton pump inhibitor use was associated with an increase in C difficile infections.

Maralixibat oral solution is indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome.

Incarceration history and current opioid agonist treatment was associated with antibody testing.

Healthcare provider knowledge on fecal microbiota transplantation as a treatment for inflammatory bowel disease is still lacking.

Only 1 patient died due to HCV-related complications following liver transplantation.

RT001 and RT176 were the most prevalent C difficile ribotypes found from C difficile isolates using PCR testing.

Patients with pediatric solid tumors and hematological malignancies were more prone to C difficile infections.

The accuracy of transient elastography following a sustained virologic response was considered poor.

FMT treatment was less effective for primary C difficile infections.

The machine learning model outperformed a comparison logistic regression model in identifying high-risk patients for HBV.

Most of Europe lacks an active and coordinated surveillance plan in place for monitoring hospital-acquired CDI.

Hospitals that use the 3-dose vaccine would spend approximately 37% more on prophylaxis for hepatitis B.

The evidence regarding patients with entecavir-treated chronic hepatitis B without maintaining virological response is limited and uncertain.

CDI rates remained down in 2020 despite an increase in antibiotic use during the pandemic.

Co-infections of HBV and HIV often lead to an increased risk of overall mortality.

Dr. Amar Deshpande said more safety studies are needed before examining whether multiple biologics can be used to treat IBD.

The new assay was 100% on both sensitivity and specificity for detecting C difficile infections from rectal swabs.

Serum concentrations of aminotransferases improved for HCC-DAA and DAA-HCC groups 1 year following surgery.

One lot of the vancomycin kits mistakenly contained a first omeprazole diluent.

Grade 3 injection site redness led to the predefined stopping rules for 10 patients in the clinical trials.

More research is needed on the safety and efficacy of multiple biologics.

IBS is considered 1 of the most expensive conditions in gastroenterology.